Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsUSPTO FDA Sustainability Intellectual Property BIOTECH biotech industry health Biotechnology Industry healthcare public policy agriculture biofuels Health Care climate change Food biotechnology Plant biotechnology Benefits of biotech crops patent BIO Events
- Most Popular
Latest VideoHans Schikan, CEO of Prosensa, on Rare Disease Drug Development View All >